Colombian Diplomat Suggests Drug Fight Could Spur Cuts In U.S. Aid

A Washington-based Colombian diplomat in a letter to his foreign minister has asked his government to change its decision to seek a compulsory license for the cancer drug Glivec, citing concern that the action could threaten U.S. funding for a Colombian peace initiative, future access to the Trans-Pacific Partnership, or give rise to a dispute under the U.S.-Colombia free trade agreement. The Office of the U.S. Trade Representative is strongly denying allegations that it tied the funding for the Colombian...